Erkan Merder

Erkan Merder

Auto-generated profile, based on publicly available information

Erkan Merder

Urology Department, Health Science University, Prof Dr Cemil Taşcıoğlu City Hospital, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2020 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
YCYeliz Culha
Yeliz Culha
EAEzgi Seyhan Ak
Ezgi Seyhan Ak
EMErkan Merder
Erkan Merder
AAAhmet Ariman
Ahmet Ariman
MCMehmet Gokhan Culha
Mehmet Gokhan Culha

8 April 2020 in The Aging Male
Verified
Journal Article
Closed access
MCMehmet Gokhan Culha
Mehmet Gokhan Culha
LCLutfi Canat
Lutfi Canat
RDRecep Burak Degirmentepe
Recep Burak Degirmentepe
AAAhmet Tevfik Albayrak
Ahmet Tevfik Albayrak
HAHasan Anil Atalay
Hasan Anil Atalay
FAFatih Altunrende
Fatih Altunrende
Aside from the ordinary plasma lipid level measurements, the ratios based on individual plasma lipid levels such as atherogenic index of plasma (AIP), Castelli’s risk index 1/2 (CRI-1/2), and atherogenic coefficient (AC) are the novel parameters to evaluate the patients with a high risk of CVD. In this study, we aim to evaluate the relationship between AIP, AC, and CRI-1/2 with increased risk of ED. Between April 2018 and February 2019, 253 patients, who were diagnosed as a vasculogenic ED in our clinic, were enrolled in the study. While the first group (n = 134) consisted of patients with moderate and mild ED (IIEF-EF: 17–30), the second group (n = 119) consisted of patients with severe ED. In addition to the mean values of lipid parameters; CRI-1 (total cholesterol/HDL), CRI-2 (LDL/HDL) AIP (log10(triglycerides/HDL), and AC (non-HDL/HDL) were calculated. The mean age was 44.02 ± 10.41 (24–70), and the mean BMI was 27.80 ± 4.12 (18.52 ± 41.97). However, CRI-1 and AIP values were found to be higher in the severe ED group compared to the mild ED group (CRI-1: 4.50 ± 1.47, 4.88 ± 1.30; p = .039; AIP: 0.489 ± 0.315, 0.617 ± 0.283; p = .007). Our results demonstrated that CR-1 and AIP have a positive correlation with the severity of ED. Moreover, we can suggest that patients with higher CR-1 and AIP values are likely to have more severe ED in the future.

27 April 2021 in Andrologia
Verified
Journal Article
Closed access
PDF file
AAAhmet Arıman
Ahmet Arıman
EMErkan Merder
Erkan Merder
MÇMehmet Gökhan Çulha
Mehmet Gökhan Çulha
BEBahadır Ermeç
Bahadır Ermeç
MKMusab Umeyir Karakanlı
Musab Umeyir Karakanlı
MAMine Adaş
Mine Adaş

7 January 2021 in Urologia Journal
Verified
Journal Article
Closed access
PDF file
EMErkan Merder
Erkan Merder
AAAhmet Arıman
Ahmet Arıman
KSKenan Sabuncu
Kenan Sabuncu
FAFatih Altunrende
Fatih Altunrende
The aim of this study is determine and compare improvement of hydronephrosis, renal function, and operative outcome between laparoscopıc and open pyeloplasty in adults. Sixty-five adult patients with primary ureteropelvic junction obstruction (UPJO) underwent pyeloplasty between January 2014 and September 2020. Thirty-four patients had laparoscopıc pyeloplasty (LP), 31 patients had open pyeloplasty (OP). In this retrospective study demographics, differential renal function (DRF), hydronephrosis, anteroposterior diameter of pelvis renalis (APD) and operative outcomes: operation time, blood loss, complications, hospital stay, etiology, analgesic requirement, complications, and success rates were compared between two groups. Improvement of APD is higher in OP group (p: 0.001). Improvement of DRF (p: 0.713) and hydronephrosis (p = 1.000), success (p: 0.407) and complication rate (p: 0.661) are comparable between two groups. Median hospital stay, postoperative analgesia requirement and blood loss was less in LP group, mean operative time was shorter in OP group (p: 0.001). Pain complaints are greatly reduced after pyeloplasty in adult patients but the drainage of kidney, DRF and hydronephrosis does not improve as much as desired. Improvement of APD is better and median operative time is less in OP, intraoperative blood loss, hospital stay, and analgesic requirement is less in LP group in our study.

10 February 2021 in Urologia Journal
Verified
Journal Article
Closed access
PDF file
AAAhmet Arıman
Ahmet Arıman
EMErkan Merder
Erkan Merder
Purpose: Testicular cancer is mostly seen in young men. We planned this study that neutrophil-lymphocyte ratio (NLR) would help us predict the prognosis of the patients, except known markers such as AFP, hCG, and LDH. Patients and Method: Between 2015 and 2020, we conducted our study on 152 patients undergoing radical orchiectomy in our clinic. We divided our patients into good, moderate, and poor prognostic groups. We also created a control group of healthy patients of similar ages. We evaluated the NLR results in preoperative peripheral blood statistically among these groups. Results: We found a significant difference between the control group and the patient group, and between the good and moderate/poor prognostic groups for preoperative NLR. Conclusion: This study created the opinion that preoperative NLR will help us predict the prognosis of patients.

1 June 2021 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
AAAhmet Ariman
Ahmet Ariman
EMErkan Merder
Erkan Merder
MÇMehmet Gökhan Çulha
Mehmet Gökhan Çulha
OBJECTIVE: Stress-type and urgency-type urinary incontinence are seen together in mixed-type urinary incontinence. Treatment is usually chosen according to the predominant type of incontinence. The aim of this study is to evaluate the effect of mirabegron and duloxetine combination in the treatment of mixed-type urinary incontinence. METHODS: The data of 88 mixed-type urinary incontinence patients who applied to the urology outpatient clinic between January 2018 and December 2019 were retrospectively analyzed. We applied mirabegron and duloxetine treatment to the patients. The International Consultation of Incontinence Questionnaire-Short Form, Overactive bladder symptom score questionnaire and daily pad count were statistically evaluated before and after the treatment. RESULTS: Statistically significant improvements were observed using the questionnaire forms and decreased daily pad usage after the eight-week treatment (p<0.001). Based on the clinical global effect scale, 62.50% of patients had a partial or complete response to treatment and also the use of daily pads were decreased from 3.7-0.89 on an average. CONCLUSION: Combination use of mirabegron and duloxetine in the treatment of mixed-type urinary incontinence improved symptom scores and decreased pad usage.